Listen Now
Topics Covered
- Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19, Delta & Omicron
- Staging & Grading
- Current Standard of Care
- Treatment Options for Resistant Disease
- Emerging Treatment Approaches
- The Role of Clinical Trials
- How Research Contributes to Treatment Choices
- Tips to Manage Side Effects, Symptoms, Discomfort & Pain
- The Increasing Role of Telehealth/Telemedicine Appointments
- Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
- Questions for Our Panel of Experts
Our Panel of Experts

Catherine S M Diefenbach, MD
Associate Professor of Medicine, Translational Director of Hematology/Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Adolfo Enrique Diaz, MD, MSc
Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Senior Director of Education and Training CancerCare
Brochure
You can download the brochure for this workshop(80.5 KB)
Workshop Date
This workshop was originally recorded on March 02, 2022.